Abstract:Chronic follicular cholecystitis (CFC) is a rare pathology characterized by prominent lymphoid follicles in the lamina propria distributed throughout the gallbladder wall. It has also been mentioned in the literature as lymphoid hyperplasia and pseudolymphoma. CFC represents less than 2% of cholecystectomies. Its etiopathology is mostly unknown. Most reports are based on histopathological findings, with little or no imaging analysis. We describe a case involving a 66-year-old man radiologically diagnosed as xa… Show more
“…Xanthogranulomatous cholecystitis is a rare variety of chronic cholecystitis 2 , 6 , 8 . XGC is a benign but occasionally aggressive disorder resulting from chronic inflammation of the gallbladder wall 1 .…”
Section: Discussionmentioning
confidence: 99%
“…Radical cholecystectomy is performed involving en bloc resection of segments IVB and V of the liver when malignancy is suspected 4 . Intraoperative frozen section analysis can be done to differentiate the differential diagnoses 6 , 8 . The postoperative mortality rate and complications are relatively low 4 .…”
Introduction:
Xanthogranulomatous cholecystitis (XGC) is an uncommon type of chronic cholecystitis. Clinical presentation, laboratory findings, and radiological analysis mimic gallbladder carcinoma. A definitive diagnosis is made by histological study. Cholecystectomy, along with adjuncts as required, is performed for management.
Case Presentation:
We present a case of a 67-year-old female who was planned for interval cholecystectomy for gallstone pancreatitis. Her clinical, laboratory and radiological findings were suggestive of cholelithiasis and was planned for laparoscopic cholecystectomy. Her intraoperative findings mimicked gallbladder carcinoma. The surgery was aborted, and a biopsy was sent for histopathological analysis. XGC was diagnosed, and the patient underwent laparoscopic cholecystectomy with no postoperative complications during the 6-month follow-up period.
Discussion:
XGC is a rare disorder resulting from chronic inflammation of the gallbladder. There is the presence of xanthogranuloma with predominant lipid-laden macrophages in the gallbladder wall along with fibrosis. Clinical presentation, laboratory findings, and radiological analysis mimic gallbladder carcinoma. Ultrasonography usually shows diffuse wall thickening of the gallbladder, intramural hypoechoic nodules, unclear liver and gallbladder interface, and the presence of gallstones. The final diagnosis is made by histopathological analysis. Laparoscopic or open cholecystectomy, along with adjuncts as required, is performed for management with a low postoperative complication rate.
Conclusion:
XGC is a rare, benign disease that is often confused with gallbladder cancer before histological analysis. XGC can be managed with laparoscopic cholecystectomy with minimal postoperative complications.
“…Xanthogranulomatous cholecystitis is a rare variety of chronic cholecystitis 2 , 6 , 8 . XGC is a benign but occasionally aggressive disorder resulting from chronic inflammation of the gallbladder wall 1 .…”
Section: Discussionmentioning
confidence: 99%
“…Radical cholecystectomy is performed involving en bloc resection of segments IVB and V of the liver when malignancy is suspected 4 . Intraoperative frozen section analysis can be done to differentiate the differential diagnoses 6 , 8 . The postoperative mortality rate and complications are relatively low 4 .…”
Introduction:
Xanthogranulomatous cholecystitis (XGC) is an uncommon type of chronic cholecystitis. Clinical presentation, laboratory findings, and radiological analysis mimic gallbladder carcinoma. A definitive diagnosis is made by histological study. Cholecystectomy, along with adjuncts as required, is performed for management.
Case Presentation:
We present a case of a 67-year-old female who was planned for interval cholecystectomy for gallstone pancreatitis. Her clinical, laboratory and radiological findings were suggestive of cholelithiasis and was planned for laparoscopic cholecystectomy. Her intraoperative findings mimicked gallbladder carcinoma. The surgery was aborted, and a biopsy was sent for histopathological analysis. XGC was diagnosed, and the patient underwent laparoscopic cholecystectomy with no postoperative complications during the 6-month follow-up period.
Discussion:
XGC is a rare disorder resulting from chronic inflammation of the gallbladder. There is the presence of xanthogranuloma with predominant lipid-laden macrophages in the gallbladder wall along with fibrosis. Clinical presentation, laboratory findings, and radiological analysis mimic gallbladder carcinoma. Ultrasonography usually shows diffuse wall thickening of the gallbladder, intramural hypoechoic nodules, unclear liver and gallbladder interface, and the presence of gallstones. The final diagnosis is made by histopathological analysis. Laparoscopic or open cholecystectomy, along with adjuncts as required, is performed for management with a low postoperative complication rate.
Conclusion:
XGC is a rare, benign disease that is often confused with gallbladder cancer before histological analysis. XGC can be managed with laparoscopic cholecystectomy with minimal postoperative complications.
“…FC is a rare diagnosis and has not been well described in the literature [4] . Differential diagnoses of FC include primary MALT lymphoma of the gallbladder, xanthogranulomatous cholecystitis, and gallbladder carcinoma [5] , [6] .…”
“…In GBC patients with p53 overexpression, the 5-year survival rate was 17.2 25 . Ki-67: In a study it was concluded that expression of Ki-67 had a worse postoperative prognosis 26 . Combining various immune markers together for diagnostic purpose led to the highest levels of sensitivity and specificity.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.